Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-α therapy in patients with pre-existing thyroid disorders

Clinical Endocrinology

Volumn 45, Issue 2, 1996, Pages 207-214

  Chen, Fu Qin ^a   Okamura, Ken ^a,b   Sato, Kaori ^a   Kuroda, Takeo ^a   Mizokami, Tetsuya ^a   Fujikawa, Megumi ^a   Tsuji, Hiroshi ^a   Okamura, Seiichi ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; RECOMBINANT ALPHA INTERFERON; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0029818902     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.d01-1564.x     Document Type: Article

References (25)

1. Amino, N., Miyai, K., Onishi, T., Hashimoto, T., Arai, K., Ishibashi, K. & Kumahara, Y. (1976) Transient hypothyroidism after delivery in autoimmune thyroiditis. Journal of Clinical Endocrinology and Metabolism, 42, 296-301.
2. Baudin, E., Marcellin, P., Pouteau, M., Colas-Linhart, N., Floch, J.-P.L., Lemmonier, C., Benhamou, J.-P. & Bok, B. (1993) Reversibility of thyroid function induced by recombinant alpha interferon in chronic hepatitis C. Clinical Endocrinology, 39, 657-661.
3. Buller, R.M.L., Holmes, K.L., Hugin, A., Frederickson, T.N. & Iii, H.C.M. (1987) Induction of cytotoxic T cells responses in vivo in the absence of CD4 helper cells. Nature, 328, 77-79.
4. Burman, P., Totterman, T.H., Oberg, K. & Karlsson, F.A. (1986) Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. Journal of Clinical Endocrinology and Metabolism, 63, 1086-1090.
5. Daniels, H.M., Meager, A., Eddleston, A.L.W., Alexander, G.J.M. & Williams, R. (1990) Spontaneous production of tumor necrosis factor alpha and interleukin-l beta during interferon-alpha treatment of chronic HBV infection, Lancet, 335, 875-877.
6. Fattovich, G., Betterle, C., Brollo, L., Pedini, B., Giustina, G., Realdi, G., Alberti, A. & Ruol, A. (1991) Autoantibodies during α-interferon therapy for chronic hepatitis B. Journal of Medical Virology, 34, 132-135.
7. Fentiman, I.S., Balkwill, F.R., Thomas, B.S., Russell, M.J., Todd, I. & Bottazzo, G.F. (1988) An autoimmune etiology for hypothyroidism following interferon therapy for breast cancer. European Journal of Cancer and Clinical Oncology, 24, 1299-1303.
8. Fonseca, V.. Thomas, M. & Dusheiko, G. (1991) Thyrotropin receptor antibodies following treatment with recombinanl α-interferon in patients with hepatitis. Acta Endocrinologica, 125, 491-493.
9. Gisslinger, H., Gilly, B., Woloszczuk, W.. Mayr, W.R., Havelec. L., Linkesch, W. & Weissel, M. (1992) Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clinical and Experimental Immunology, 90, 363-367.
10. Harfast, B., Huddlestone, J.R. Casali, P., Merigan, T.C. & Oldstone, M.B.A. (1981) Interferon acts directly on human B lymphocytes to modulate imniunoglobulin synthesis. Journal of Immunology, 127, 2146-2150.
11. Ikematsu, W.. Ikematsu, H., Okamura, S.. Otsuka, T., Harada, M. & Niho, Y. (1994) Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: Expression of myclomonocytic surface markers in CD5-chronic B-cell leukemia. Blood, 83, 2602-2610.
12. Imagawa, A.. Itoh, N., Hanafusa, T., Oda, Y.. Waguri, M., Miyagawa, J.-I., Kono, N., Kumajima, M. & Malsuzawa, Y. (1995) Autoimmune endocrine disease induced by recombinant interferon-α therapy for chronic active type C hepatitis. Journal of Clinical Endocrinology and Metabolism, 80, 922-926.
13. Ingimarsson, S., Cantell, K. & Strander, H. (1979) Side effects of long-term treatment with human leukocyte interferon. Journal of Infectious Diseases, 140, 560-563.
14. Inoue, D., Sato, K., Sugawa, H., Akamizu, T., Maeda, M., Inoko, H., Tsuji, K. & Mori, T. (1993) Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody and those without, as shown by restriction fragment length polymorphism analyses of HLA-DP loci. Journal of Clinical Endocrinology and Metabolism, 77, 606-610.
15. Jansson, R., Totterman, T.H., Sallstrom, J. & Dahlberg, P.A. (1984) Intrathyroidal and circulating lymphocyte subsets in different stages of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology and Metabolism, 58, 942-946.
16. Lindahl, P., Leary, P. & Grosser, I. (1972) Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proccedings of the National Academy of Science of the United States of America, 69, 721-725.
17. Lisker-Melman, M. Di-Biseglie, A.M., Usala, S.J., Weintraub, B., Murray, L.M. & Hoofnagle, J.H. (1992) Development of thyroid disease during therapy of chronic viral hepatitis with Interferon alfa. Gastroenterology, 102, 2155-2160.
18. Nagayama, Y., Ohta, K., Tsuruta, M., Takeshita, A., Kimura, H., Hamasaki, K., Ashizawa, K., Nakata, K., Yokoyama, N. & Nagataki, S. (1994) Exacerbation of thyroid autoimmunity by interferon α treatment in patients With chronic viral hepatitis: our studies and review of the literature, Endocrine Journal, 41, 565-572.
19. Okamura, K., Sato, K., Ikenoue, H., Yoshinari, M., Nakagawa, M,. Kuroda, T. & Fujishima, M. (1988) Reevaluation of the thyroidal radioactive iodine uptake test, with special reference to reversible primary hypothyroidism with elevated thyroid radioiodine uptake. Journal of Clinical Endocrinology and Metabolism, 67, 720-726.
20. Okamura, K., Sato, K., Yoshinari, M., Ikenoue, H., Kuroda, T., Nagakawa, M., Tsuji, H., Washio, M. & Fujishima, M. (1990) Recovery of thyroid function in patients with atrophic hypothyroidism and blocking type TSH binding inhibitor imniunoglobulin, Acta Endocrinologica, 122, 107-114.
21. Papo, T., Oksenhendler, E., Izembart, M.. Leger, A. & Clauvel, J.-P. (1992) Antithyroid hormone antibodies induced by interferon-α. Journal of Clinical Endocrinology and Metabolism, 75, 1484-1486.
22. Renault, P.F., Hoofnagle, J.H., Park, Y., Mullen, K.D., Peters, M., Jones, D.B. Rustgi, V. & Jones, E.A. (1987) Psychiatric complications of long-term interferon alfa therapy. Archives of Internal Medicine, 147, 1577-1580.
23. Ronnblom, L.E.. Alm, G.V. & Oberg, K.E. (1991) Autoimmunity alter alpha-interferon therapy for malignant carcinoid tumors. Annals of Internal Medicine, 115, 178-183.
24. Sato, K., Okamura, K., Yoshinari, M., Ikenoue, H., Kuroda, T., Torisu, M. & Fujishima, M. (1990) Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins. Journal of Clinical Endocrinology and Metabolism, 71, 855-860.
25. Watanabe, U., Hashimoto, E., Hisamitsu, T., Obata, H. & Hayashi, N. (1994) The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. American Journal of Gastroenterology, 89, 399-403.